A new trading day began on Friday, with OnKure Therapeutics Inc (NASDAQ: OKUR) stock price up 16.35% from the previous day of trading, before settling in for the closing price of $2.63. OKUR’s price has ranged from $1.70 to $15.89 over the past 52 weeks.
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 4.41%. Meanwhile, its annual earnings per share averaged 70.16%. With a float of $8.09 million, this company’s outstanding shares have now reached $12.86 million.
OnKure Therapeutics Inc (OKUR) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of OnKure Therapeutics Inc is 40.31%, while institutional ownership is 50.34%. The most recent insider transaction that took place on Sep 22 ’25, was worth 231. In this transaction President and CEO of this company sold 88 shares at a rate of $2.62, taking the stock ownership to the 3,506 shares. Before that another transaction happened on Sep 22 ’25, when Company’s Chief Financial Officer sold 303 for $2.62, making the entire transaction worth $795. This insider now owns 12,603 shares in total.
OnKure Therapeutics Inc (OKUR) Performance Highlights and Predictions
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -1.37 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.15 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 70.16% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 41.03% during the next five years compared to 4.41% growth over the previous five years of trading.
OnKure Therapeutics Inc (NASDAQ: OKUR) Trading Performance Indicators
Here are OnKure Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 11.45.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.17, a number that is poised to hit -1.15 in the next quarter and is forecasted to reach -3.73 in one year’s time.
Technical Analysis of OnKure Therapeutics Inc (OKUR)
The latest stats from [OnKure Therapeutics Inc, OKUR] show that its last 5-days average volume of 0.28 million was superior to 0.11 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 38.27%.
During the past 100 days, OnKure Therapeutics Inc’s (OKUR) raw stochastic average was set at 67.06%, which indicates a significant decrease from 74.65% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.28 in the past 14 days, which was higher than the 0.22 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.96, while its 200-day Moving Average is $2.97. Now, the first resistance to watch is $3.28. This is followed by the second major resistance level at $3.51. The third major resistance level sits at $3.83. If the price goes on to break the first support level at $2.73, it is likely to go to the next support level at $2.41. Assuming the price breaks the second support level, the third support level stands at $2.18.
OnKure Therapeutics Inc (NASDAQ: OKUR) Key Stats
With a market capitalization of 41.46 million, the company has a total of 13,548K Shares Outstanding. Currently, annual sales are 0 K while annual income is -52,670 K. The company’s previous quarter sales were 0 K while its latest quarter income was -14,700 K.
